Enzymotec Signs Krill Deal with India Pharma Company
Enzymotec Ltd. has signed a long term deal to supply krill oil to Lupin Ltd. (Mumbai, India), a leading pharmaceutical company focusing on non-steroidal anti-inflammatory drugs, bacterial infections, and cardiovascular disease.
Enzymotec Ltd. (Migdal HaEmek, Israel) has signed a long term deal to supply krill oil to Lupin Ltd. (Mumbai, India), a leading pharmaceutical company focusing on non-steroidal anti-inflammatory drugs, bacterial infections, and cardiovascular disease.
Lupin is the world’s fifth largest pharmaceutical company, based on subscriptions, says Enzymotec.
A Krill Oil+ product will launch later this year in Indian markets.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
